287 related articles for article (PubMed ID: 22149217)
1. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery.
Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM
Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217
[TBL] [Abstract][Full Text] [Related]
2. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression.
Kauffman KJ; Kanthamneni N; Meenach SA; Pierson BC; Bachelder EM; Ainslie KM
Int J Pharm; 2012 Jan; 422(1-2):356-63. PubMed ID: 22037446
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product.
Kauffman KJ; Do C; Sharma S; Gallovic MD; Bachelder EM; Ainslie KM
ACS Appl Mater Interfaces; 2012 Aug; 4(8):4149-55. PubMed ID: 22833690
[TBL] [Abstract][Full Text] [Related]
4. Multimodal delivery of irinotecan from microparticles with two distinct compartments.
Rahmani S; Park TH; Dishman AF; Lahann J
J Control Release; 2013 Nov; 172(1):239-245. PubMed ID: 23973814
[TBL] [Abstract][Full Text] [Related]
5. Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery.
Wang Z; Gupta SK; Meenach SA
Int J Pharm; 2017 Jun; 525(1):264-274. PubMed ID: 28450166
[TBL] [Abstract][Full Text] [Related]
6. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
[TBL] [Abstract][Full Text] [Related]
7. Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight.
Chen N; Collier MA; Gallovic MD; Collins GC; Sanchez CC; Fernandes EQ; Bachelder EM; Ainslie KM
Int J Pharm; 2016 Oct; 512(1):147-157. PubMed ID: 27543351
[TBL] [Abstract][Full Text] [Related]
8. Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.
Peine KJ; Bachelder EM; Vangundy Z; Papenfuss T; Brackman DJ; Gallovic MD; Schully K; Pesce J; Keane-Myers A; Ainslie KM
Mol Pharm; 2013 Aug; 10(8):2849-57. PubMed ID: 23768126
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Feng R; Zhang Z; Li Z; Huang G
Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
11. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
[TBL] [Abstract][Full Text] [Related]
12. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
13. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
14. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
[TBL] [Abstract][Full Text] [Related]
15. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
[TBL] [Abstract][Full Text] [Related]
16. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
17. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
18. Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
Patel B; Rashid J; Ahsan F
Eur J Pharm Sci; 2017 Jan; 96():560-570. PubMed ID: 27989858
[TBL] [Abstract][Full Text] [Related]
19. Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of Applications.
Bachelder EM; Pino EN; Ainslie KM
Chem Rev; 2017 Feb; 117(3):1915-1926. PubMed ID: 28032507
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid).
Ghassemi AH; van Steenbergen MJ; Talsma H; van Nostrum CF; Jiskoot W; Crommelin DJ; Hennink WE
J Control Release; 2009 Aug; 138(1):57-63. PubMed ID: 19409427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
